Merck (MRK) EBT (2009 - 2026)
Merck's EBT came in at -$683 million for Q2 2026, compared with $5 billion a year earlier.
Powered by 
Analysis
Merck (MRK) EBT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Merck reported EBT of $5.95 billion, down 69.0% year-over-year; for FY2025, it was $21.07 billion, up 5.7% from FY2024.
- EBT carries a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
- Going back by year, EBT was $19.94 billion in FY2024 (+955.4%), $1.89 billion in FY2023 (-88.5%), $16.44 billion in FY2022 (+18.5%) and $13.88 billion in FY2021 (+136.7%).
- The five-year range for quarterly EBT is -$5.34 billion (Q2 2023) to $6.75 billion (Q3 2025).
- Year-over-year, EBT increased in two of the last five quarters, with growth averaging 1.4%.
- The fastest year-over-year change in EBT over five years came in Q2 2022 (growth of 161.3%), and the weakest in Q3 2022 (a decline of 32.0%).
- Business Quant data shows MRK's EBT at -$3.53 billion (Q1 2026), $3.42 billion (Q4 2025) and $6.75 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 4.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -683.00 Mn |
| Mar 31, 2026 | -3.53 Bn |
| Dec 31, 2025 | 3.42 Bn |
| Sep 30, 2025 | 6.75 Bn |
| Jun 30, 2025 | 5.00 Bn |
| Mar 31, 2025 | 5.90 Bn |
| Dec 31, 2024 | 4.17 Bn |
| Sep 30, 2024 | 4.09 Bn |
| Jun 30, 2024 | 6.01 Bn |
| Mar 31, 2024 | 5.67 Bn |
| Dec 31, 2023 | -2.05 Bn |
| Sep 30, 2023 | 5.62 Bn |
| Jun 30, 2023 | -5.34 Bn |
| Mar 31, 2023 | 3.65 Bn |
| Dec 31, 2022 | 3.51 Bn |
| Sep 30, 2022 | 3.58 Bn |
| Jun 30, 2022 | 4.49 Bn |
| Mar 31, 2022 | 4.86 Bn |
| Dec 31, 2021 | 3.91 Bn |
| Sep 30, 2021 | 5.27 Bn |
API Access
Merck EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();